ANDA 219647, held by Novitium Pharma. Tramadol Hydrochloride.
As of Nov 16, 2026, ANDA 219647 (Tramadol Hydrochloride), held by Novitium Pharma, was first approved by FDA on Jun 26, 2026, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 26, 2026 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tramadol Hydrochloride5MG/ML ยท solution;oral | Tramadol Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters